ag-1296 and pyrazolanthrone

ag-1296 has been researched along with pyrazolanthrone in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A1
Hanai, Y; Harada, A; Kato, H; Kozawa, O; Matsushima-Nishiwaki, R; Ogura, S; Takai, S; Tokuda, H1

Other Studies

2 other study(ies) available for ag-1296 and pyrazolanthrone

ArticleYear
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
    The Biochemical journal, 2013, Apr-15, Volume: 451, Issue:2

    Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase

2013
Potentiation by platelet-derived growth factor-BB of FGF-2-stimulated VEGF release in osteoblasts.
    Journal of bone and mineral metabolism, 2008, Volume: 26, Issue:4

    Topics: Animals; Animals, Newborn; Anthracenes; Becaplermin; Cell Line; Dose-Response Relationship, Drug; Drug Synergism; Fibroblast Growth Factor 2; Flavonoids; JNK Mitogen-Activated Protein Kinases; Mice; Mitogen-Activated Protein Kinase 3; Models, Biological; Osteoblasts; Phosphorylation; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Receptor, Platelet-Derived Growth Factor beta; Tyrphostins; Vascular Endothelial Growth Factor A

2008